Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

Importance of biologics in rheumatoid arthritis management

bracu.degree.levelUndergraduate
bracu.type.groupStudent Works
datacite.rightsOpen Access
dc.contributor.advisorHaque, Md. Aminul
dc.contributor.authorRiyadh, S. M.
dc.contributor.departmentDepartment of Pharmacy
dc.date.accessioned2022-04-04T03:30:48Z
dc.date.available2022-04-04T03:30:48Z
dc.date.copyright2021
dc.date.issued2021-12
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 27-33).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.description.abstractRheumatoid arthritis (RA) is an autoimmune condition that causes chronic joint inflammation pain, eventually leading to significant bone and cartilage damage in the affected joint. Around the world, RA affects a large number of people in their later years. The most frequent joints affected by RA are the elbow, shoulder and metacarpophalangeal joints. Conventional medication previously only treated the symptoms of RA. To treat the etiology of RA, biological disease modifying anti-rheumatic medicines (bDMARDs) target biological receptors such as TNF-alpha, IL-1 and IL-6. This review article discusses the benefits of using biological disease modifiers.en_US
dc.description.degreeBachelor of Pharmacy
dc.description.statementofresponsibilityS. M. Riyadh
dc.format.extent33 pages
dc.identifier.otherID 17146009
dc.identifier.urihttp://hdl.handle.net/10361/16507
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectRheumatoid arthritisen_US
dc.subjectTNF-alphaen_US
dc.subjectInterleukinen_US
dc.subjectDisease-modifying anti rheumatic drugsen_US
dc.subjectBiological disease-modifying anti rheumatic drugsen_US
dc.subject.lcshRheumatoid arthritis -- Pathogenesis.
dc.titleImportance of biologics in rheumatoid arthritis managementen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
17146009_PHR.pdf
Size:
1.79 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: